Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China ...

Discover the history of insulin, from its discovery to modern production methods, and the ongoing quest for a cure.

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

Anjana RM, Unnikrishnan R, Deepa M, et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB ...

Pancreatic cancer is a serious condition that is often diagnosed at advanced stages, making early detection and awareness ...

Dr Kshetrimayum Kala SinghContd from previous issueIt is mandatory to register all the patients with necessary mobile phones, Whatsapp & e-mail for future correspondence.All the family members should ...

Garrett H. Garner, MD, Medical Director at SimpleFixRx to review it all for accuracy. Dr, Garner said, "Glucagon-like peptide ...

When this process is disrupted, glucose builds up in the blood, leading to high blood sugar levels. The DMC offers programs ...